ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference
Hand-out
Press Releases
ITF Therapeutics LLC  
March 17, 2025

ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference

Seven abstracts highlight long-term effects, consistent safety profile, and delayed disease progression with givinostat

avatar profile Olean Times Herald

Olean Times Herald


Local & Social